Charles Reed Cherington is an entrepreneur who founded Paratus Capital Management, Amberjack Capital Partners LP, Cherington Capital LLC and Ara Advisers LLC. Currently, he is Chairman for Brooklyn ImmunoTherapeutics, Inc., Manager of Brooklyn ImmunoTherapeutics LLC (a subsidiary of Brooklyn ImmunoTherapeutics, Inc.), Partner at Amberjack Capital Partners LP and Managing Partner at Ara Advisers LLC. Charles Reed Cherington is also Manager for Brooklyn ImmunoTherapeutics LLC and on the board of 8 other companies.
In the past Mr. Cherington occupied the position of President & Director at FCG Chemical, Inc., Vice President for Vietnam Fund Ltd., Partner at Paratus Capital Management, Principal at CS First Boston Pacific, Inc. and Partner at Cherington Capital LLC.
Charles Reed Cherington received an MBA from The University of Chicago and an undergraduate degree from Wesleyan University.